Details for Patent: 6,878,721
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 6,878,721 protect, and when does it expire?
Patent 6,878,721 protects ARCAPTA NEOHALER and UTIBRON and is included in two NDAs.
This patent has forty-nine patent family members in thirty-four countries.
Summary for Patent: 6,878,721
Title: | Beta2-adrenoceptor agonists |
Abstract: | Compounds of formula ##STR1## in free or salt or solvate form, where Ar is a group of formula ##STR2## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases. |
Inventor(s): | Cuenoud; Bernard (Horsham, GB), Bruce; Ian (Horsham, GB), Fairhurst; Robin Alec (Horsham, GB), Beattie; David (Horsham, GB) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 10/009,008 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,878,721 |
Patent Claim Types: see list of patent claims | Compound; Composition; Use; Process; |
Drugs Protected by US Patent 6,878,721
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | ARCAPTA NEOHALER | indacaterol maleate | POWDER;INHALATION | 022383-001 | Jul 1, 2011 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | Y | THE LONG TERM, ONCE-DAILY MAINTENANCE BRONCHODILATOR TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA | See Plans and Pricing | ||
Novartis | UTIBRON | glycopyrrolate; indacaterol maleate | POWDER;INHALATION | 207930-001 | Oct 29, 2015 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | Y | LONG-TERM MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | See Plans and Pricing | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,878,721
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 9913083 | Jun 04, 1999 |
PCT Information | |||
PCT Filed | June 02, 2000 | PCT Application Number: | PCT/EP00/05058 |
PCT Publication Date: | December 14, 2000 | PCT Publication Number: | WO00/75114 |
International Family Members for US Patent 6,878,721
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 035548 | See Plans and Pricing | |||
Austria | 440083 | See Plans and Pricing | |||
Australia | 5074500 | See Plans and Pricing | |||
Australia | 765919 | See Plans and Pricing | |||
Belgium | 2010C011 | See Plans and Pricing | |||
Brazil | 0011324 | See Plans and Pricing | |||
Canada | 2375810 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |